Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dietary macromolecules in the gastrointestinal lumen encompass the primary nutritional components—carbohydrates, proteins, and lipids—ingested through the diet. These molecules are essential for providing energy and structural precursors but must be enzymatically hydrolyzed into smaller units like monosaccharides, amino acids, and fatty acids before absorption (National Institute of Diabetes and Digestive and Kidney Diseases, 2017). In clinical pharmacology, these macromolecules are not typically viewed as individual molecular targets but rather as a substrate environment that can be manipulated. Therapeutic strategies often involve the use of binders or sequestrants, such as phosphate binders for hyperphosphatemia, which physically interact with specific luminal components to prevent their systemic uptake (StatPearls, 2023). Additionally, the rate and extent of macromolecule digestion can be modulated by inhibiting digestive enzymes, thereby managing conditions like type 2 diabetes and obesity (DrugBank, 2024). Because this term describes a heterogeneous group of substances rather than a single molecular entity, it is generally considered a physiological compartment or substrate class rather than a specific therapeutic target.
Physical sequestration, adsorption, or chemical binding of dietary components within the gastrointestinal lumen to prevent their systemic absorption or to facilitate their excretion.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dietary macromolecules in gastrointestinal lumen (None).